Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder AsiaPacific Fund Regulatory News (SDP)

Share Price Information for Schroder AsiaPacific Fund (SDP)

Share Price is delayed by 15 minutes
Get Live Data
852.00    -2.00 (-0.23%)
Bid:
852.00
Ask:
855.00
Spread: 3.00 (0.352%)
Market Cap: £1.07b
SDP Live PriceLast checked at - London Stock Exchange

Intraday Schroder AsiaPacific Fund Share Chart

Directorate change

17 Apr 2026 07:00

RNS Number : 8266A
Schroder AsiaPacific Fund PLC
17 April 2026
 

17 April 2026

Schroder AsiaPacific Fund plc

Directorate Change

 

Schroder AsiaPacific Fund plc (the "Company") is pleased to announce the appointment of John Lydon as an independent non-executive Director of the Company, with effect from 1 May 2026. He will also be a member of the Audit and Risk, Nomination and Management Engagement Committees.

Mr Lydon has over 30 years' experience in M&A, capital markets, strategic advisory and investment across Europe, Asia, and North America. He has held various leadership roles in the financial sector at J.P. Morgan, Deutsche Bank and Davy Group, and in the industrial sector at CRH plc. Mr Lydon is currently a Venture Partner at Princeville Capital, a leading global growth-stage technology investor.

 

Nicky Richards, Chair of the Board, commented:

 

"The Board is pleased to welcome John Lydon as an independent non-executive Director. His deep international experience in M&A, capital markets and strategic advisory will add strength to the Board and its Committees. We look forward to working with him."

 

 

It is confirmed that there are no other details to be disclosed concerning Mr Lydon under UK Listing Rule 6.4.8R.

 

Enquiries:

 

Natalia de Sousa

Schroder Investment Management Limited

Tel: 0207 658 6000

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPUWUCUPQGQQ
Date   Source Headline
17th Dec 202411:08 amRNSNet Asset Value(s)
16th Dec 20245:07 pmRNSTransaction in Own Shares
16th Dec 202410:34 amRNSNet Asset Value(s)
13th Dec 20245:01 pmRNSTransaction in Own Shares
13th Dec 202410:14 amRNSNet Asset Value(s)
12th Dec 20245:34 pmRNSTransaction in Own Shares
12th Dec 202410:44 amRNSNet Asset Value(s)
11th Dec 202411:08 amRNSNet Asset Value(s)
10th Dec 202411:06 amRNSNet Asset Value(s)
9th Dec 202411:04 amRNSNet Asset Value(s)
6th Dec 20244:58 pmRNSTransaction in Own Shares
6th Dec 202411:12 amRNSNet Asset Value(s)
5th Dec 20244:59 pmRNSTransaction in Own Shares
5th Dec 202410:32 amRNSNet Asset Value(s)
4th Dec 20245:17 pmRNSPortfolio Update
4th Dec 202410:59 amRNSNet Asset Value(s)
3rd Dec 20245:41 pmRNSAnnual Financial Report on NSM
3rd Dec 20245:30 pmRNSTransaction in Own Shares
3rd Dec 202410:45 amRNSNet Asset Value(s)
3rd Dec 20247:01 amRNSDividend Declaration
3rd Dec 20247:00 amRNSFinal Results
2nd Dec 202410:45 amRNSNet Asset Value(s)
29th Nov 20245:26 pmRNSTotal Voting Rights
29th Nov 20244:50 pmRNSTransaction in Own Shares
29th Nov 202410:50 amRNSNet Asset Value(s)
28th Nov 202410:27 amRNSNet Asset Value(s)
27th Nov 20245:32 pmRNSTransaction in Own Shares
27th Nov 202410:19 amRNSNet Asset Value(s)
26th Nov 20244:54 pmRNSTransaction in Own Shares
26th Nov 202410:25 amRNSNet Asset Value(s)
25th Nov 20245:01 pmRNSTransaction in Own Shares
25th Nov 202411:19 amRNSNet Asset Value(s)
22nd Nov 20245:03 pmRNSTransaction in Own Shares
22nd Nov 202410:14 amRNSNet Asset Value(s)
21st Nov 20244:48 pmRNSTransaction in Own Shares
21st Nov 202410:53 amRNSNet Asset Value(s)
20th Nov 20245:06 pmRNSTransaction in Own Shares
20th Nov 202410:46 amRNSNet Asset Value(s)
19th Nov 20244:56 pmRNSTransaction in Own Shares
19th Nov 202410:55 amRNSNet Asset Value(s)
18th Nov 20244:42 pmRNSTransaction in Own Shares
18th Nov 202411:08 amRNSNet Asset Value(s)
15th Nov 20244:44 pmRNSTransaction in Own Shares
15th Nov 202411:05 amRNSNet Asset Value(s)
14th Nov 20245:01 pmRNSTransaction in Own Shares
14th Nov 202410:24 amRNSNet Asset Value(s)
13th Nov 20245:25 pmRNSTransaction in Own Shares
13th Nov 202410:45 amRNSNet Asset Value(s)
12th Nov 202410:32 amRNSNet Asset Value(s)
11th Nov 20244:32 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.